Till Uhlig

13.5k total citations
205 papers, 7.0k citations indexed

About

Till Uhlig is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Till Uhlig has authored 205 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Rheumatology, 37 papers in Hematology and 29 papers in Surgery. Recurrent topics in Till Uhlig's work include Rheumatoid Arthritis Research and Therapies (142 papers), Systemic Lupus Erythematosus Research (48 papers) and Autoimmune and Inflammatory Disorders Research (36 papers). Till Uhlig is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (142 papers), Systemic Lupus Erythematosus Research (48 papers) and Autoimmune and Inflammatory Disorders Research (36 papers). Till Uhlig collaborates with scholars based in Norway, Netherlands and Sweden. Till Uhlig's co-authors include Tore K Kvien, Glenn Haugeberg, Sigrid Ødegård, Johan Halse, Jan A. Falch, Espen A. Haavardsholm, Petter Mowinckel, Kåre Birger Hagen, Rikke Helene Moe and Désirée van der Heijde and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Till Uhlig

185 papers receiving 6.8k citations

Peers

Till Uhlig
Sofía Ramiro Netherlands
Till Uhlig
Citations per year, relative to Till Uhlig Till Uhlig (= 1×) peers Sofía Ramiro

Countries citing papers authored by Till Uhlig

Since Specialization
Citations

This map shows the geographic impact of Till Uhlig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Uhlig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Uhlig more than expected).

Fields of papers citing papers by Till Uhlig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Till Uhlig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Uhlig. The network helps show where Till Uhlig may publish in the future.

Co-authorship network of co-authors of Till Uhlig

This figure shows the co-authorship network connecting the top 25 collaborators of Till Uhlig. A scholar is included among the top collaborators of Till Uhlig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Till Uhlig. Till Uhlig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uhlig, Till, et al.. (2025). Remission in gout is possible: 5-year follow-up in the NOR-Gout study. Seminars in Arthritis and Rheumatism. 72. 152698–152698. 1 indexed citations
2.
Dalbeth, Nicola, Sarah Stewart, Greg Gamble, et al.. (2025). Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia. Arthritis Care & Research. 78(3). 417–423.
3.
Vedder, Daisy, Anna Rudin, Dan Nordström, et al.. (2024). Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study. RMD Open. 10(4). e004838–e004838.
4.
Lillegraven, Siri, et al.. (2024). Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls. Rheumatology Advances in Practice. 9(1). rkaf017–rkaf017. 1 indexed citations
5.
Sexton, Joe, Lena Bugge Nordberg, Till Uhlig, et al.. (2024). Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials. RMD Open. 10(3). e004444–e004444. 1 indexed citations
6.
Uhlig, Till, Joe Sexton, Sella Aarrestad Provan, et al.. (2024). Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study. Lara D. Veeken. 64(4). 1799–1806. 3 indexed citations
8.
Moe, Rikke Helene, Peter Solvoll Lyby, Ingvild Kjeken, et al.. (2023). Work Ability in the Year after Rehabilitation—Results from the RehabNytte Cohort. Journal of Clinical Medicine. 12(23). 7391–7391. 2 indexed citations
9.
Lillegraven, Siri, Anna‐Birgitte Aga, Joseph Sexton, et al.. (2023). Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial. Annals of the Rheumatic Diseases. 82(11). 1394–1403. 6 indexed citations
10.
Smedslund, Geir, et al.. (2022). Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments. Rheumatology International. 42(12). 2109–2124. 1 indexed citations
11.
Hammer, Hilde Berner, Brigitte Michelsen, Joseph Sexton, et al.. (2019). Swollen, but not tender joints, are independently associated with ultrasound synovitis: results from a longitudinal observational study of patients with established rheumatoid arthritis. Annals of the Rheumatic Diseases. 78(9). 1179–1185. 35 indexed citations
12.
Aga, Anna‐Birgitte, Inge Christoffer Olsen, Hilde Berner Hammer, et al.. (2018). Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes. Annals of the Rheumatic Diseases. 77(10). 1421–1425. 28 indexed citations
13.
Michelsen, Brigitte, Till Uhlig, Joseph Sexton, et al.. (2018). Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Annals of the Rheumatic Diseases. 77(9). 1290–1294. 22 indexed citations
14.
Klokkerud, Mari, Hanne Dagfinrud, Till Uhlig, et al.. (2017). Developing and testing a consensus-based core set of outcome measures for rehabilitation in musculoskeletal diseases. Scandinavian Journal of Rheumatology. 47(3). 225–234. 31 indexed citations
15.
Nordberg, Lena Bugge, Siri Lillegraven, Elisabeth Lie, et al.. (2016). Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria. Annals of the Rheumatic Diseases. 76(2). 341–345. 87 indexed citations
16.
Haavardsholm, Espen A., Anna‐Birgitte Aga, Inge Christoffer Olsen, et al.. (2015). Aiming for Remission in Rheumatoid Arthritis : Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen. Data Archiving and Networked Services (DANS). 67. 4 indexed citations
17.
Aga, Anna‐Birgitte, Hilde Berner Hammer, Inge Christoffer Olsen, et al.. (2015). First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach. Annals of the Rheumatic Diseases. 75(8). 1444–1451. 13 indexed citations
18.
Uhlig, Till, et al.. (2008). Nasjonalt register for ny og kostbar behandling. Tidsskrift for Den Norske Laegeforening.
19.
Uhlig, Till, et al.. (2007). Spesialisert rehabilitering av pasienter med revmatisk sykdom. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
20.
Uhlig, Till, Arnstein Finset, & Tore K Kvien. (2003). Effectiveness and cost-effectiveness of comprehensive rehabilitation programs. Current Opinion in Rheumatology. 15(2). 134–140. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026